Why can’t we develop COVID-19 treatments faster?
Ask the doctor
COVID-19 is an unprecedented public health emergency. Why can't we go faster in developing drugs for it that are effective and safe?In the United States, the FDA approves drugs to treat specific diseases. To prove to the FDA that a drug is effective and safe, doctors need time. A large number of patients need to be recruited and followed to see whether the drug has worked and whether it has produced dangerous side effects — and that all takes time. If doctors cut corners, they can draw the wrong conclusions about whether the drug is effective and safe.
To continue reading this article, you must log in.
Subscribe to Harvard Health Online for immediate access to health news and information from Harvard Medical School.
- Research health conditions
- Check your symptoms
- Prepare for a doctor's visit or test
- Find the best treatments and procedures for you
- Explore options for better nutrition and exercise
I'd like to receive access to Harvard Health Online for only $4.99 a month.
Sign Me UpAlready a member? Login ».
Disclaimer:
As a service to our readers, Harvard Health Publishing provides access to our library of archived content. Please note the date of last review or update on all articles.
No content on this site, regardless of date, should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
